GTR Home > Tests > Search results - GBE1[gene]

Apply filters

Showing tests for all 2474 conditions

Compare labs

Your search term can be found in tests with a total of 2474 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states
More locations

GTR test search results for 2632[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 47 tests for 2474 conditions in 19 labs

CMetabolic myopathies panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (25)

CGlycogen storage disease type IV

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAndersen disease

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

CLeukodystrophy NGS Panel

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (124)
Total targets (128)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CGlycogen Storage Disease NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (15)
Total targets (14)

CGBE1 Sequence Analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CGBE1 Deletion/Duplication Analysis

Test targets
Methods
  • D Deletion/duplication analysis

CGBE1 Comprehensive - Sequence & Deletion/Duplication Analysis

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CGlycogen Storage Disease Type IV via the GBE1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CGBE1 Mutation Analysis

Lab: Molecular Diagnostics Laboratory Duke University Health System Durham, North Carolina, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CAtaxia and differential diagnoses Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (174)
Total targets (147)

CMetabolic Myopathies Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (26)
Total targets (40)

CGlycogen storage disease type 4, GBE1 gene, sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region

CGBE1

Test targets
Methods
  • S Mutation scanning of the entire coding region

CNeuropathy

Total conditions (7)
Total targets (122)

CSevere Recessive Childhood Diseases

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (436)

Showing 1 to 20 of 47 tests for 2474 conditions in 19 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.